Latest News
Connect Biopharma Holdings Limited
- Connect Biopharma Holdings (NasdaqGM:CNTB) Stock Forecast & Analyst Predictions
- Connect Biopharma (NASDAQ:CNTB) Coverage Initiated by Analysts at Leerink Partners
- H.C. Wainwright reiterates Buy on Connect Biopharma stock
- Connect Biopharma (NASDAQ:CNTB) Stock Rating Reaffirmed as "Buy" by HC Wainwright
- A holder reports sole voting power over 400,000 Connect Biopharma (CNTB) shares, plus shared ownership.
- Q3 EPS Estimate for Connect Biopharma Reduced by Analyst
- Connect Biopharma COPD Study Shows 81% Cut in Treatment Failures
- Why is Connect Biopharma stock surging today?
- Why Is Connect Biopharma Stock Trading Higher Today? - Connect Biopharma Hldgs (NASDAQ:CNTB)
- Connect Biopharma stock jumps on positive COPD trial data
- Connect’s Dupixent rival reduces COPD attacks by 85%, but misses a secondary goal
- Connect Biopharma Announces Positive Preliminary Topline Data from its Global Phase 2 Study of Rademikibart as an Add-on Treatment for Acute Exacerbations in Adults with COPD and Type 2 Inflammation
Headlines from the last 30 days, linking to the original publishers. See all market news →